期刊文献+

疏肝健脾方药对非酒精性脂肪性肝病大鼠肝组织UCP2 mRNA及蛋白表达的影响 被引量:10

Effect of Soothing Liver and Invigorating Spleen Recipes on UCP2 mRNA and Protein Expression in Hepatic Tissues of Rats with Non Alcoholic Fatty Liver Disease
下载PDF
导出
摘要 目的观察疏肝健脾方药对非酒精性脂肪性肝病(non-alcoholic fatty liver disease,NAFLD)大鼠肝组织解偶联蛋白2(uncoupling protein 2,UCP2)mRNA及蛋白表达的影响,初步探讨疏肝健脾方药治疗NAFLD的作用机制。方法采用高脂饲料喂养12周复制雄性SD大鼠NAFLD模型,将模型大鼠分为疏肝组、健脾组、疏肝健脾综合组(综合组)、三七脂肝丸组(三七组)、模型组,各组给予相应治疗8周。测定各组大鼠血清总胆固醇、三酰甘油、低密度脂蛋白胆固醇和高密度脂蛋白胆固醇含量。采用RT-PCR方法检测肝组织UCP2 mRNA的表达,免疫组织化学方法检测肝组织中UCP2蛋白活性变化。结果与正常组比较,模型组大鼠肝组织中UCP2 mRNA表达水平显著升高(P<0.05);与模型组比较,疏肝组、健脾组和综合组UCP2 mRNA表达水平显著下降(P<0.05)。模型组肝组织UCP2蛋白表达水平显著升高;与模型组比较,各用药组UCP2蛋白表达水平均显著下调(P<0.01)。结论疏肝健脾方药可使NAFLD大鼠肝组织中UCP2基因和蛋白表达水平降低。 Objective To observe effects of soothing liver and invigorating spleen recipes on expression levels of uncoupling protein 2 (UCP2) mRNA and UCP2 protein in hepatic tissues of rats with non-alcoholic fatty liver disease(NAFLD), to preliminarily explore the possible mechanism. Methods Male SD rat model of NAFLD was induced by feeding with high fat diets for 12 weeks. Then model rats were averagely subdivided into 5 subgroups: Soothing Liver group, Invigorating Spleen group, Soothing Liver and Invigorating Spleen group (Integrated group), Sanqi Zhigan Wan (pellets including Panax pseudo ginseng for fatty liver) group (Sanqi group), and model group. After treated correspondingly for eight weeks, serum levels of total cholesterol, triglyceride, low density lipoprotein-cholesterol and high density lipoprotein cholesterol of each group were assayed. Expression levels of UCP2 mRNA and UCP2 protein in hepatic tissues were assayed using reverse transcription polymerase chain reaction and immunohistochemistry, respectively. Results Compared with that of normal group, the expression level of UCP2 mRNA in rat he patio tissues of model group was significantly increased (P〈0.05). Compared with that of model group, the expression level of UCP2 mRNA in Soothing Liver group, Invigorating Spleen group and Integrated group was decreased (P〈0.05). The expression level of UCP2 protein was significantly increased in the model group. Compared with that of model group, expression levels of UCP2 protein in treated groups were significantly decreased (P〈0. 01). Conclusion Soothing liver and invigorating spleen recipes can down-regulate expression levels of UCP2 mRNA and UCP2 protein in hepatic tissues of NAFLD rats.
出处 《安徽中医学院学报》 CAS 2010年第2期56-59,共4页 Journal of Anhui Traditional Chinese Medical College
基金 国家中医药管理局科研专项基金(02-03JP39) 广东省中医药管理局科研课题(2050041)
关键词 非酒精性脂肪性肝病 解偶联蛋白2 疏肝健脾 Non-alcoholic fatty liver disease Uncoupling protein 2 Soothing liver and invigorating spleen
  • 相关文献

参考文献9

  • 1Tarantino G,Saldalamacchia G,Conca P,et al.Non-alcoholic fatty liver disease:Further expression of the metabolic syndrome[J].J Gastroenterol Hepatol,2007,22(3):293-303.
  • 2Utzschneider KM,Kahn SE.Review:The role of insulin resistance in nonalcoholic fatty liver disease[J].J Clin Endocrinol Metab,2006,91(12):4753-4761.
  • 3Falck-Ytter Y,Younossi ZM,Marehesini G.Clinical features and natural history of nonalcoholic steatosis syndromes[J].Semin Liver Dis,2001,21:17-26.
  • 4李文岗,张学文,何尔斯泰,胡素贤.大鼠脂肪肝模型的建立[J].吉林大学学报(医学版),2004,30(2):233-235. 被引量:15
  • 5许济群.方剂学[M].5版.上海:上海科学技术出版社,2003:50,94.
  • 6谢维宁,杨钦河,王强.从肝脾论治脂肪肝[J].时珍国医国药,2007,18(2):328-329. 被引量:14
  • 7杨钦河,周迎春,郭桃美,张薇,潘丰满,夏棣其,唐纯志,孙景波,孔令人,胡巢凤,李菁,王斌会,戚仁斌,王彦平.不同治法方药对脂肪肝大鼠血脂作用的比较研究[J].新中医,2004,36(5):74-75. 被引量:18
  • 8Cortez Pinto H,ZHi lin H,Qi Yang S.Lipids up-regulate uncoupling protein-2 expression in rat hepatocytes[J].Gastroenterology,1999,116:1184-1193.
  • 9Hong Y,Fink BD,Dillon JS.Effects of adenoviral over expression of uncoupling protein-2 and -3 on mitochondrial respiration in insulinoma cells[J].Endocrinology,2001,142(1):249-56.

二级参考文献24

  • 1贾桂燕,张晶,韩立坤,郑毅男.人参皂苷降脂作用的研究[J].天然产物研究与开发,2005,17(2):160-162. 被引量:35
  • 2严彦彪,尹吉恒.柴胡疏肝散加味治疗脂肪肝68例[J].河北中医,2005,27(12):927-927. 被引量:10
  • 3韩德五 马学惠 等.肝硬化动物模型的研究[J].山西医药杂志,1979,(1):1-1.
  • 4陈关良.中药配合自血光量子治疗酒精性脂肪肝36例[J].实用中医药杂志,1997,13(6):21-21.
  • 5Teramoto K, John L, Bower S, et al. A rat fatty liver transplant model [J]. Transplantation, 1993, 55: 737-741.
  • 6Lindros KO, Jarvelainen HA. A new oral low-carbohydrate alcohol liquid diet producing liver lesion: a preliminary account [J]. Alcohol, 1998, 33: 347-353.
  • 7Keegan A, Martini R, Batey R. Ethanol-related liver injury in the rat: a model of steatosis, inflammation and pericentral fibrosis [J]. J Hepatol, 1995, 23: 591-600.
  • 8Delzenne NM, Hernaux NA, Taper HS. A new model of acute liver steatosis induced by refeeding a high carbohydrate-fat free diet. Biochemical and morphological analysis [J].J Hepatol, 1997, 26: 880-885.
  • 9Soga M, Kishimoto Y, Kawaguchi J, et al. The FIS mouse: a new inbred strain with spontaneous fatty liver [J]. Lab Anim Sci, 1999, 49: 269-275.
  • 10Ibrahim KM, Nicola WG, Salama SH, et al. Mechanism of insulin resistance and hyper-insulinemia in fatty liver[J]. Boll ChimFarm, 1996, 135: 528-540.

共引文献44

同被引文献114

引证文献10

二级引证文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部